Oz Azam beefs up Tmunity's total raise to $231M as they steer toward human data in the drive to cell therapy 2.0
The CEO of Tmunity believes that if you want to build a different kind of cell therapy company, you need a different kind of investor syndicate to back your play.
So Usman “Oz” Azam is particularly jazzed that the Silicon Valley gurus at Andreessen Horowitz elected to lead the latest round at the Philadelphia-based biotech, adding $75 million today to a total raise that now tallies up to $231 million.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 84,800+ biopharma pros reading Endpoints daily — and it's free.